Company intelligence / Profile preview

Hall Associates Consulting

Ownership: Private
Development stage: Other

Overview

Hall Associates Consulting is led by Professor Lowell H. Hall, a physical chemist known for pioneering computational methods to represent molecular structures. The firm specializes in developing non-empirical descriptors like the electrotopological state index and molecular connectivity indices that are widely used in quantitative structure–activity relationship (QSAR) studies to support rational drug design. These technologies have been foundational in theoretical medicinal chemistry but the company itself does not conduct clinical trials or develop drugs directly.

Modalities: Small moleculeComputational chemistry methods
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Hall Associates Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hall Associates Consulting.

Explore the full profile